Evidence map›Paper›PMID 31516309›Full record

ArticleMolecular vision2019

Genomic/proteomic analyses of dexamethasone-treated human trabecular meshwork cells reveal a role for GULP1 and ABR in phagocytosis.

Jennifer A Faralli, Harini Desikan, Jennifer Peotter, Nitin Kanneganti, Benjamin Weinhaus, Mark S Filla, Donna M Peters

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Measurements of Phagocytosis in Trabecular Meshwork Cells.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jennifer A FaralliDepartment of Pathology & Laboratory Medicine, University of Wisconsin, Madison, WI.
Harini DesikanDepartment of Pathology & Laboratory Medicine, University of Wisconsin, Madison, WI.
Jennifer PeotterDepartment of Pathology & Laboratory Medicine, University of Wisconsin, Madison, WI.
Nitin KannegantiDepartment of Pathology & Laboratory Medicine, University of Wisconsin, Madison, WI.
Benjamin WeinhausDepartment of Pathology & Laboratory Medicine, University of Wisconsin, Madison, WI.
Mark S FillaDepartment of Pathology & Laboratory Medicine, University of Wisconsin, Madison, WI.
Donna M PetersDepartment of Pathology & Laboratory Medicine, University of Wisconsin, Madison, WI.
University of Wisconsin–Madison · US

Funding

UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI Donna M Peters · 2005 to 2026
$12.6M
Control of Trabecular Meshwork CytoskeletonR01EY017006 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI PETERS, DONNA M · 2006 to 2024
$6.1M
Control of ECM HomeostasisR01EY026009 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI PETERS, DONNA M · 2016 to 2019
$1.4M
NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY017006NEI NIH HHS R01 EY026009
6 · The paper itself

Abstract

Purpose: The purpose of this study is to examine the expression profile of genes related to integrin-mediated phagocytosis that are altered by dexamethasone (DEX) and/or αvβ3 integrin signaling to gain a better understanding of the molecular basis of phagocytosis and the pathophysiology of glucocorticoid-induced ocular hypertension. Methods: RNA and cell lysates were obtained from human trabecular meshwork (HTM) cells incubated with and without DEX for 4-5 d. The relative level of gene expression was evaluated using the Affymetrix Gene Chip® human gene microarray and quantitative PCR (qPCR). Changes in protein expression were validated using western blots or FACS analyses. The involvement of proteins in phagocytosis was determined using siRNA to knock down the expression of these proteins in an immortalized TM-1 cell line. Changes in the phagocytic activity were measured using pHrodo™-labeled Results: Gene microarrays revealed statistically significant differences (>2 fold) in the expression of seven genes known to be involved in phagocytosis. Three genes ( Conclusion: The DEX-induced inhibition of phagocytosis may be caused by the downregulation of ABR and GULP1 disrupting the αvβ5 integrin/RAC1-mediated engulfment pathway. The downregulation of GULP1 by αvβ3 integrin further suggests that this integrin may be a negative regulator of phagocytosis by transcriptionally downregulating proteins needed for phagocytosis. In summary, these results represent new insights into the effects of glucocorticoids and integrin signaling on the phagocytic process in the TM.

Indexed as

PhagocytosisProteomicsAdaptor Proteins, Signal TransducingAdultAntigens, CDAntigens, DifferentiationAntigens, SurfaceCell LineDexamethasoneFemaleFocal Adhesion Protein-Tyrosine KinasesGene Expression RegulationGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsHumansIntegrin beta3ABR protein, humanAdaptor Proteins, Signal TransducingAntigens, CDAntigens, DifferentiationAntigens, SurfaceDexamethasoneFocal Adhesion Protein-Tyrosine KinasesGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsGULP1 protein, humanintegrin alphaVbeta5Integrin beta3ITGB3 protein, humanLigandsMFGE8 protein, humanMilk Proteinsrac1 GTP-Binding ProteinRAC1 protein, humanReceptors, ImmunologicReceptors, VitronectinRNA, MessengerSIRPA protein, human

Identifiers

PMID31516309
PMCPMC6706170
OpenAlexW2969825478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.